Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures. Its products also comprise instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.

Asensus Surgical, Inc.

Intelligent Health organizes a healthtech summit that connects clinicians, technologists, and executives to discuss the use of AI in medicine. The summit aims to advance conversations and collaboration in the healthcare sector, focusing on innovations and solutions in health technology.

Intelligent Health

Advanced Bionics designs and manufactures cochlear implants and hearing technology, self-described as providing solutions for individuals with hearing loss.

Advanced Bionics

Cyber Surgery develops innovative robotic assistants for seamless spinal procedures, focusing on surgical planning and vertebral fusion.

Cyber Surgery

Asensus Surgical develops robotic surgery systems and technology to provide real-time surgical insights and enhance decision-making in the operating room. The company is self-described as a pioneer in the use of Augmented Intelligence in surgery.

Metric
Company Name	Asensus Surgical, Inc.	Intelligent Health	Advanced Bionics	Cyber Surgery
Symbol	ASXC
MSH ID	COM:ASENSUS	AI:INTELLIGENTHEALTH	COM:ADVANCEDBIONICS	COM:CYBER-SURGERY
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Devices	Health Technology	Medical Devices	Medical Devices
Country	US	CH	US	ES
Stage				Non Equity Assistance
Employee Count	207
Website	asensus.com	intelligenthealth.ai	advancedbionics.com	cyber-surgery.com
LinkedIn		intelligent-health-ai-ltd		cyber-surgery
Founders

Metric
Market Cap	91.27M
Enterprise Value
Monthly Web Traffic		1.45K	33.21K	463
Web Traffic Growth		-0.76	-0.65
Valuation
Raised Capital

Metric
Revenue	8.58M
Revenue (LTM)
Revenue (NTM)
Gross Profit	-5.03M
EBITDA	-74.40M
Operating Income	-78.13M
Net Income	-78.43M
EPS	-0.31
Diluted EPS	-0.31
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	-0.34
Operating Profit Margin	-7.22
EBITDA Margin	-8.67
Net Profit Margin	-8.51
Return on Equity	-1.10
Return on Assets	-1.12
Return on Capital Employed	50.15

COM:ASENSUS

Asensus Surgical

Last Close

0.35

21/08 20:00

Market Cap

91.27M

Beta: -

Volume Today

3.94M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-0.84
P/B Ratio	1.40
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	11.84
EV Multiple	-0.87

Metric
Days Sales Outstanding	43.07
Days Payables Outstanding	147.66
Days Inventory Outstanding	218.03
Operating Cycle	346.59
Cash Conversion Cycle	232.56
Asset Turnover	0.26

Metric
Operating Cash Flow	-63.63M
Free Cash Flow	-64.19M
Cash Flow to Debt	-2.77
Operating Cash Flow/Sales	-5.75
Free Cash Flow Yield	-0.95

Metric
Cash & Equivalents	17.10M
Accounts Receivable	-1.18M
Inventory	7.17M
Goodwill
Debt to Capitalization	2.24
Debt to Assets	0.08
Current Ratio	3.79
Quick Ratio	2.78

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	1.42
R&D to Revenue	6.58
SG&A to Revenue	3.56